Triple-negative breast cancer (TNBC) exhibits substantial primary resistance to immune checkpoint blockade (ICB), a challenge driven largely by a desmoplastic and immunosuppressive tumor microenvironment (TME). Emerging multi-omics and spatial profiling technologies have unveiled the peripheral nervous system— specific...
Chang-Yuan Guo· Nature Cell and Science· 0 citations
Backgroud Breast cancer is a leading cause of cancer-related mortality, and HR+/HER2− is the predominant subtype. Molecular pathology, including PIK3CA and ESR1 mutation, informs prognosis and treatment selection. Circulating tumor DNA (ctDNA) offers a non-invasive approach for cancer monitoring, but its clinical utili...
Heng-Yi Xu, Peng-Ming Pu, Bin-Liang Liu et al.· bioRxiv· 0 citations
A unified spatial-molecular atlas of DCIS-IBC progression is established, highlighting clonal expansion, transcriptional plasticity and TME remodeling as key drivers of invasion.
Di Wang, Qichen Dai, Jing Guo et al.· Nature Communications· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.